STATE OF NEW YORK IN ASSEMBLY

Similar documents
2018 Kentucky Senate Bill No. 5, Kentucky 2018 Regular Session KENTUCKY BILL TEXT

AN ACT relating to pharmacy benefits in the Medicaid program, and declaring an. Be it enacted by the General Assembly of the Commonwealth of Kentucky:

IC Chapter 28. Independent Adjuster Licensing

PBM MODEL A A MODEL ACT RELATING TO PHARMACY BENEFIT MANAGERS*

As Introduced. Regular Session H. B. No

S 2788 SUBSTITUTE A AS AMENDED ======== LC004226/SUB A ======== S T A T E O F R H O D E I S L A N D

STATE OF NEW JERSEY. SENATE, No th LEGISLATURE. Sponsored by: Senator NIA H. GILL District 34 (Essex and Passaic)

Pharmacy Benefit Manager Licensure and Solvency Protection Act

THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL INTRODUCED BY EICHELBERGER, ARGALL, RAFFERTY, VULAKOVICH AND BROWNE, MAY 18, 2018 AN ACT

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2001 SESSION LAW SENATE BILL 904

As Passed by the House. Regular Session H. B. No

CHAPTER 58-29E PHARMACY BENEFITS MANAGEMENT

Follow this and additional works at:

Referred to Committee on Commerce, Labor and Energy. SUMMARY Revises provisions relating to policies of health insurance.

54TH LEGISLATURE - STATE OF NEW MEXICO - FIRST SESSION, 2019

PUBLIC ADJUSTER LICENSING MODEL ACT

Statutes Relevant to the Education and Licensure of Fire Sprinkler Inspectors KRS 198B (6401) (6417) Enacted 2010

Emergency Rule Filing Form

1 HB By Representative Martin. 4 RFD: Insurance. 5 First Read: 11-FEB-16. Page 0

1 SB By Senator Marsh. 4 RFD: Banking and Insurance. 5 First Read: 19-MAY-15. Page 0

80th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 572

79th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 98

AN ACT relating to pharmacy benefit management. Be it enacted by the General Assembly of the Commonwealth of Kentucky:

260 Act LAWS OF PENNSYLVANIA. No AN ACT

House Bill 2387 Ordered by the House April 27 Including House Amendments dated April 27

SUBCHAPTER 50 INSURANCE PRODUCERS AND OTHER NON-INSURER LICENSEES. This Part is promulgated pursuant to R.I. Gen. Laws et seq. and

CHAPTER 22 MISSISSIPPI NONPROFIT DEBT MANAGEMENT SERVICES ACT [REPEALED EFFECTIVE JULY 1, 2006] Section

79th OREGON LEGISLATIVE ASSEMBLY Regular Session. House Bill Corrected Sponsor

UNOFFICIAL COPY OF SENATE BILL 281 A BILL ENTITLED

9/10/18. Talkin Title. Structure of Department of Insurance. Who Handles Title? Created by: Krystle Ledvina Garcia

Referred to Committee on Commerce, Labor and Energy

77th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. House Bill 2123

RULES OF TENNESSEE DEPARTMENT OF COMMERCE AND INSURANCE DIVISION OF INSURANCE CHAPTER SELF-INSURED WORKERS COMPENSATION SINGLE EMPLOYERS

WASHINGTON STATE LAWS AND RULES Washington Administrative Code (WAC) Title 284 Revised Code of Washington (RCW) Title 48

IC Chapter 2. Farm Mutual Insurance Companies

SENATE ENROLLED ACT No. 421

IC Chapter 4. Broker-Dealers, Agents, Investment Advisers, Investment Adviser Representatives, and Federal Covered Investment Advisers

Common to Life, Disability, Property and Casualty Insurance

AN ACT. Be it enacted by the General Assembly of the State of Ohio:

Licensed/Self-Employed Adjusters...14 Independent Adjusters...14 Public Adjusters...14 Non-Licensed Adjusters ) Licensing & Examination

Information Maintained by the Office of Code Revision Indiana Legislative Services Agency IC Chapter 22. Pharmacy Audits

CHAPTER 23 THIRD PARTY ADMINISTRATORS

7) Licensing & Examination Exemptions ( ,.062, 110) D. Appointments / Termination of Appointments ( , , 490)...

Authorized By: Richard J. Badolato, Commissioner, Department of Banking and Insurance.

REVISED PROPOSED REGULATION OF THE COMMISSIONER OF MORTGAGE LENDING. LCB File No. R January 4, 2019

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 H 2 HOUSE BILL 156 Senate Health Care Committee Substitute Adopted 6/22/17

Substitute House Bill No Public Act No

Enrolled Copy H.B. 70 HEALTH DISCOUNT PROGRAM CONSUMER PROTECTION ACT. Chief Sponsor: James A. Dunnigan Senate Sponsor: Michael G.

Nevada s Oral Anticancer Treatment Access Law: What What Clinicians Need to Know

80th OREGON LEGISLATIVE ASSEMBLY Regular Session. House Bill Sponsored by Representative NOSSE; Representative SANCHEZ (Presession filed.

79th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. Senate Bill 98

THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL

A Bill Regular Session, 2015 SENATE BILL 688

ASSEMBLY, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED JULY 11, 2014

Florida Senate SB 1106

Maryland Fair Debt Collection Practices Act

1 SB By Senators Beasley, Smitherman, Irons, Bussman and Ross. 4 RFD: Health. 5 First Read: 12-APR-11. Page 0

Chapter RCW UNAUTHORIZED INSURERS

H 5323 S T A T E O F R H O D E I S L A N D

CHAPTER Committee Substitute for House Bill No. 577

ASSEMBLY, No. 455 STATE OF NEW JERSEY. 218th LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2018 SESSION

LEGISLATURE 2017 BILL. reporting by manufacturers and providing a penalty.

TENNESSEE SECURITIES DIVISION and TENNESSEE INSURANCE DIVISION, Petitioner, s, vs. KT INVESTMENTS, LLC, and DERRICK TRENT FORTNER, Respondents.

FINANCIAL INSTITUTION AGREEMENT

IC Chapter 34. Limited Service Health Maintenance Organizations

DISTRICT OF COLUMBIA DEPARTMENT OF INSURANCE, SECURITIES AND BANKING NOTICE OF EMERGENCY AND PROPOSED RULEMAKING

Senate Bill No. 91 Senator Hardy

NOTICE OF PRIVACY PRACTICES

79th OREGON LEGISLATIVE ASSEMBLY Regular Session. House Bill 4005

Public Employees Benefits Program Legislative Session Bill Tracking Updated: 3/27/2017

District of Columbia Official Code

Public Act No

TITLE 73. PROFESSIONS AND VOCATIONS CHAPTER 21. PHARMACISTS PHARMACY BENEFIT PROMPT PAY ACT. Miss. Code Ann (2013)

(Current through 2018 Regular Legislative Session) PART XIV. LOAN BROKERS

South Carolina General Assembly 121st Session,

Licensing Requirements

UNOFFICIAL COPY OF HOUSE BILL 1040 A BILL ENTITLED

NO. 80. AN ACT RELATING TO INCREASING TRANSPARENCY OF PRESCRIPTION DRUG PRICING AND INFORMATION. (S.115)

S 0831 S T A T E O F R H O D E I S L A N D

SENATE BILL NOS. 905 & 910

Assembly Bill No. 425 Committee on Commerce and Labor

RULES OF TENNESSEE DEPARTMENT OF COMMERCE AND INSURANCE INSURANCE DIVISION CHAPTER SELF-INSURED WORKERS COMPENSATION POOLS

SOAH DOCKET NO C TDI CASE NO Argus Health Systems, Inc. Administrative Hearings. First Amended Notice of Hearing

Assembly Bill No CHAPTER 824

HEALTH MAINTENANCE ORGANIZATION ACT Act of Dec. 29, 1972, P.L. 1701, No. 364 AN ACT Providing for the establishment of nonprofit corporations having

(Reprinted with amendments adopted on April 24, 2017) FIRST REPRINT A.B. 249 MARCH 1, Referred to Committee on Health and Human Services

Senate Amendment to Senate Bill No. 539 (BDR ) Title: Yes Preamble: No Joint Sponsorship: No Digest: Yes

TITLE 230 DEPARTMENT OF BUSINESS REGULATION

NC General Statutes - Chapter 78D Article 1 1

Charles E. Cunningham vs. Commerce and Insurance

As Introduced. 132nd General Assembly Regular Session S. B. No

House Bill 2339 Ordered by the House April 7 Including House Amendments dated April 7

TITLE 43 CREDIT TRANSACTION CODE TABLE OF CONTENTS

ADMINISTRATIVE COMPLAINT. You, WILLIAM PAGE AND ASSOCIATES, INC., (William Page), are hereby

THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL INTRODUCED BY WHITE, STREET, BARTOLOTTA, COSTA, FONTANA AND BREWSTER, APRIL 18, 2017 AN ACT

Pharmacy Benefit Managers Overview

CHAPTER 47. REGULATION OF TRADE. ARTICLE 14. PRENEED FUNERAL CONTRACTS.

H. R IN THE HOUSE OF REPRESENTATIVES

S 2467 S T A T E O F R H O D E I S L A N D

The statutory basis for this rule entitled Mortgage Loan Originator Temporary License, is section , C.R.S.

Transcription:

A 10985 Gottfried Same as S 8934 RIVERA Public Health Law TITLE...Provides for pharmacy benefit management and the procurement of prescription drugs at a negotiated rate for dispensation; repealer 05/29/18 referred to health S8934 RIVERA Same as A 10985 Gottfried ON FILE: 06/06/18 Public Health Law TITLE...Provides for pharmacy benefit management and the procurement of prescription drugs at a negotiated rate for dispensation; repealer 06/06/18 REFERRED TO RULES STATE OF NEW YORK 10985 IN ASSEMBLY May 29, 2018 Introduced by M. of A. GOTTFRIED -- read once and referred to the Committee on Health AN ACT to amend the public health law, in relation to pharmacy benefit managers; and to repeal certain provisions of such law relating thereto The People of the State of New York, represented in Senate and Assembly, do enact as follows: 1 Section 1. Section 280-a of the public health law is REPEALED and a 2 new section 280-a is added to read as follows: 3 280-a. Pharmacy benefit managers. 1. Definitions. As used in this 4 section, the following terms shall have the following meanings: 5 (a) "Health plan or provider" means an entity for which a pharmacy 6 benefit manager provides pharmacy benefit management including, but not 7 limited to: (i) a health benefit plan or other entity that approves, 8 provides, arranges for, or pays for health care items or services, under 9 which prescription drugs for beneficiaries of the entity are purchased 10 or which provides or arranges reimbursement in whole or in part for the 11 purchase of prescription drugs; or (ii) a health care provider or 12 professional, including a state or local government entity, that 13 acquires prescription drugs to use or dispense in providing health care 14 to patients. 15 (b) "Pharmacy benefit management" means the service provided to a 16 health plan or provider, directly or through another entity, and regard- 17 less of whether the pharmacy benefit manager and the health plan or 18 provider are related, or associated by ownership, common ownership, 19 organization or otherwise; including the procurement of prescription 20 drugs to be dispensed to patients, or the administration or management 21 of prescription drug benefits, including but not limited to, any of the 22 following: 23 (i) mail service pharmacy; 24 (ii) claims processing, retail network management, or payment of 25 claims to pharmacies for dispensing prescription drugs; 26 (iii) clinical or other formulary or preferred drug list development 27 or management; EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD16054-01-8 A. 10985 2

1 (iv) negotiation or administration of rebates, discounts, payment 2 differentials, or other incentives, for the inclusion of particular 3 prescription drugs in a particular category or to promote the purchase 4 of particular prescription drugs; 5 (v) patient compliance, therapeutic intervention, or generic substi- 6 tution programs; and 7 (vi) disease management. 8 (c) "Pharmacy benefit manager" means any entity that performs pharmacy 9 benefit management for a health plan or provider. 10 (d) "Maximum allowable cost price" means a maximum reimbursement 11 amount set by the pharmacy benefit manager for therapeutically equiv- 12 alent multiple source generic drugs. 13 (e) "Controlling person" means any person or other entity who or which 14 directly or indirectly has the power to direct or cause to be directed 15 the management, control or activities of a pharmacy benefit manager. 16 (f) "Covered individual" means a member, participant, enrollee, 17 contract holder or policy holder or beneficiary of a health plan or 18 provider. 19 (g) "License" means a license to be a pharmacy benefit manager, under 20 subdivision seven of this section. 21 2. Duty, accountability and transparency. (a) The pharmacy benefit 22 manager shall have a fiduciary relationship with and obligation to the 23 health plan or provider, and shall perform pharmacy benefit management 24 with care, skill, prudence, diligence, and professionalism. 25 (b) All funds received by the pharmacy benefit manager in relation to 26 providing pharmacy benefit management shall be received by the pharmacy 27 benefit manager in trust for the health plan or provider and shall be 28 used or distributed only pursuant to the pharmacy benefit manager's 29 contract, or other terms in the absence of a contract, with the health 30 plan or provider or applicable law; except for any fee or payment 31 expressly provided for in the contract, or other terms in the absence of 32 a contract, between the pharmacy benefit manager and the health plan or 33 provider to compensate the pharmacy benefit manager for its services. 34 (c) The pharmacy benefit manager shall periodically account to the 35 health plan or provider for all funds received by the pharmacy benefit 36 manager. The health plan or provider shall have access to all financial 37 and utilization information of the pharmacy benefit manager in relation 38 to pharmacy benefit management provided to the health plan or provider. 39 (d) The pharmacy benefit manager shall disclose in writing to the 40 health plan or provider the terms and conditions of any contract or 41 arrangement between the pharmacy benefit manager and any party relating 42 to pharmacy benefit management provided to the health plan or provider. 43 (e) The pharmacy benefit manager shall disclose in writing to the 44 health plan or provider any activity, policy, practice, contract or 45 arrangement of the pharmacy benefit manager that directly or indirectly 46 presents any conflict of interest with the pharmacy benefit manager's 47 relationship with or obligation to the health plan or provider. 48 (f) Any information required to be disclosed by a pharmacy benefit 49 manager to a health plan or provider under this section that is reason- 50 ably designated by the pharmacy benefit manager as proprietary or trade 51 secret information shall be kept confidential by the health plan or 52 provider, except as required or permitted by law, including disclosure 53 necessary to prosecute or defend any legitimate legal claim or cause of 54 action. 55 (g) The commissioner shall establish, by regulation, minimum standards 56 for pharmacy benefit management services which shall address the elimi- A. 10985 3

1 nation of conflicts of interest between pharmacy benefit managers and 2 health insurers, plans and providers; and the elimination of deceptive 3 practices, anti-competitive practices, and unfair claims practices. 4 3. Prescriptions. A pharmacy benefit manager may not substitute or 5 cause the substituting of one prescription drug for another in dispens- 6 ing a prescription, or alter or cause the altering of the terms of a 7 prescription, except with the approval of the prescriber or as explicit- 8 ly required or permitted by law. 9 4. Appeals. A pharmacy benefit manager shall, with respect to 10 contracts between a pharmacy benefit manager and a pharmacy or, alterna- 11 tively, a pharmacy benefit manager and a pharmacy's contracting agent, 12 such as a pharmacy services administrative organization, include a 13 reasonable process to appeal, investigate and resolve disputes regarding 14 multi-source generic drug pricing. The appeals process shall include the 15 following provisions: 16 (a) the right to appeal by the pharmacy and/or the pharmacy's 17 contracting agent shall be limited to thirty days following the initial 18 claim submitted for payment; 19 (b) a telephone number through which a network pharmacy may contact 20 the pharmacy benefit manager for the purpose of filing an appeal and an 21 electronic mail address of the individual who is responsible for proc- 22 essing appeals; 23 (c) the pharmacy benefit manager shall send an electronic mail message 24 acknowledging receipt of the appeal. The pharmacy benefit manager shall 25 respond in an electronic message to the pharmacy and/or the pharmacy's 26 contracting agent filing the appeal within seven business days indicat- 27 ing its determination. If the appeal is determined to be valid, the 28 maximum allowable cost for the drug shall be adjusted for the appealing 29 pharmacy effective as of the date of the original claim for payment. The 30 pharmacy benefit manager shall require the appealing pharmacy to reverse 31 and rebill the claim in question in order to obtain the corrected 32 reimbursement; 33 (d) if an update to the maximum allowable cost is warranted, the phar- 34 macy benefit manager or covered entity shall adjust the maximum allow- 35 able cost of the drug effective for all similarly situated pharmacies in 36 its network in the state on the date the appeal was determined to be 37 valid; and 38 (e) if an appeal is denied, the pharmacy benefit manager shall identi- 39 fy the national drug code of a therapeutically equivalent drug, as 40 determined by the federal Food and Drug Administration, that is avail- 41 able for purchase by pharmacies in this state from wholesalers regis- 42 tered pursuant to subdivision four of section sixty-eight hundred eight 43 of the education law at a price which is equal to or less than the maxi- 44 mum allowable cost for that drug as determined by the pharmacy benefit 45 manager. 46 5. Contract provisions. No pharmacy benefit manager shall, with 47 respect to contracts between such pharmacy benefit manager and a pharma- 48 cy or, alternatively, such pharmacy benefit manager and a pharmacy's 49 contracting agent, such as a pharmacy services administrative organiza- 50 tion: 51 (a) prohibit or penalize a pharmacist or pharmacy from disclosing to 52 an individual purchasing a prescription medication information regard- 53 ing: 54 (1) the cost of the prescription medication to the individual, or A. 10985 4

1 (2) the availability of any therapeutically equivalent alternative 2 medications or alternative methods of purchasing the prescription medi- 3 cation, including but not limited to, paying a cash price; or 4 (b) charge or collect from an individual a copayment that exceeds the 5 total submitted charges by the pharmacy for which the pharmacy is paid. 6 If an individual pays a copayment, the pharmacy shall retain the adjudi- 7 cated costs and the pharmacy benefit manager shall not redact or recoup 8 the adjudicated cost. 9 6. Acting without a license. (a) No person or entity may act as a 10 pharmacy benefit manager on or after January first, two thousand twenty 11 without having a currently valid license under this section. However, a 12 pharmacy benefit manager providing pharmacy benefit management on and 13 before that date may continue to do so without a license under this 14 section for a period of one hundred eighty days. 15 (b) No health plan or provider may pay any fee or other compensation 16 for pharmacy benefit management to any person or entity acting in 17 violation of this subdivision. 18 (c) Any person or entity that violates this section shall be subject 19 to penalties under sections twelve and twelve-b of this chapter. 20 7. Licensing of pharmacy benefit managers. (a) The commissioner may 21 issue a pharmacy benefit manager license to any person or entity who or 22 that applies for a license and has complied with the requirements of 23 this section. The commissioner may establish, by regulation, minimum 24 standards for the issuance of a license to a pharmacy benefit manager. 25 The term of each license shall be a period of five years and may be 26 renewed by the commissioner. 27 (b)(1) Before a pharmacy benefit manager's license shall be issued or 28 renewed, the prospective licensee shall file a written application in 29 such form or forms and supplements as the commissioner may require, and 30 pay a fee of ten thousand dollars. 31 (2) Every license issued pursuant to this section may be renewed by 32 filing the application and paying the fees at least sixty days prior to 33 the expiration of the license, upon which the license shall continue in 34 full force and effect until either (A) the issuance by the commissioner 35 of the renewed license or (B) five business days after the commissioner 36 shall have given notice to the applicant that the commissioner has 37 rejected the renewal. 38 (c) The commissioner may refuse to issue or renew a pharmacy benefit 39 manager's license if, in the commissioner's judgment, the applicant or 40 any member, principal, officer or director of the applicant, is not 41 trustworthy or competent to act as a pharmacy benefit manager, or if the 42 commissioner is aware of cause for revocation or suspension of such 43 license. The commissioner shall notify the licensee of a determination 44 to reject the application for the license or renewal and an explanation 45 of the cause for rejection, and shall provide a reasonable opportunity 46 for the licensee to be heard under subdivision eight of this section. 47 (d) Licensees shall be subject to examination at any time by the 48 commissioner. 49 8. Revocation or suspension of a license. (a) The commissioner, upon 50 his or her own investigation or complaint from another party, may 51 revoke, suspend or refuse to renew a license if, after notice and hear- 52 ing, the commissioner determines that the licensee, has, in relation to 53 pharmacy benefit management or the operation of the pharmacy benefit 54 manager: 55 (1) violated any law, regulation, subpoena or order of the commission- 56 er, or of another state that would constitute a violation in New York; A. 10985 5

1 (2) provided materially incorrect, materially misleading, materially 2 incomplete or materially untrue information in a license application; 3 (3) obtained or attempted to obtain a license through misrepresen- 4 tation or fraud; 5 (4) used fraudulent, coercive or dishonest practices; 6 (5) demonstrated incompetence; 7 (6) demonstrated untrustworthiness; 8 (7) demonstrated financial irresponsibility in the conduct of the 9 business; 10 (8) improperly withheld, misappropriated or converted any monies or 11 properties; 12 (9) intentionally misrepresented the terms of an actual or proposed 13 contract with any party; 14 (10) been convicted of a felony; 15 (11) had a pharmacy benefit manager license, or its equivalent, 16 denied, suspended or revoked in any other state, province, district or 17 territory; or 18 (12) ceased to meet the requirements for licensure under this section. 19 (b) Before revoking, suspending or refusing to renew a license, the 20 commissioner shall give notice to the licensee and shall hold, or cause 21 to be held, a hearing as provided under section twelve-a of this chap- 22 ter. The commissioner shall also give notice to health plans and provid- 23 ers under contract with the pharmacy benefit manager, to the extent 24 known to the commissioner. 25 (c) If a license is revoked or suspended, the commissioner shall give 26 notice to the licensee and health plans and providers under contract 27 with the pharmacy benefit manager to the extent known to the commission- 28 er. 29 9. Change of address. A registrant or licensee under this section 30 shall inform the commissioner by a means acceptable to the commissioner 31 of a change of address within thirty days of the change. 32 10. Violations. Any provision of a contract that violates the 33 provisions of this section shall be deemed to be void and unenforceable. 34 2. Severability. If any provision of this act, or any application 35 of any provision of this act, is held to be invalid, or ruled by any 36 federal agency to violate or be inconsistent with any applicable federal 37 law or regulation, that shall not affect the validity or effectiveness 38 of any other provision of this act, or of any other application of any 39 provision of this act. 40 3. This act shall take effect on the ninetieth day after it shall 41 become a law and shall apply to any contract for providing pharmacy 42 benefit management made or renewed on or after that date. Effective 43 immediately, the commissioner of health shall make regulations and take 44 other actions reasonably necessary to implement this act on that date.

BILL NUMBER: A10985 SPONSOR: Gottfried NEW YORK STATE ASSEMBLY MEMORANDUM IN SUPPORT OF LEGISLATION submitted in accordance with Assembly Rule III, Sec 1(f) TITLE OF BILL: An act to amend the public health law, in relation to pharmacy benefit managers; and to repeal certain provisions of such law relating thereto PURPOSE OR GENERAL IDEA OF BILL: This bill requires licensure for pharmacy benefit managers (PBMs) and specifies their duties and obligations as service providers. SUMMARY OF SPECIFIC PROVISIONS: The bill amends Public Health Law 280-a to provide that PBMs have a fiduciary relationship with health plan or health care provider clients, require that funds they receive belong to the client except for fees for services specifically provided for by contract, require full disclosure to clients, and bars the substitution of prescribed drugs (subdivisions 1-3). Subdivision 4 is current subdivision 2 renumbered, and subdivision 5 renumbers a provision that was added as part of the 2018 state budget. Subdivisions 6 through 9 require PBMs to be licensed, renewable every five years, with a fee of $10,000. The bill establishes grounds and procedure for suspension, revocation or refusal to grant or renew a license. Existing PBMs are provided an additional 180 days to comply with the initial licensure. Grounds for disciplinary action include fraudulent applications or practices, incompetence, financial irresponsibility, and felony conviction, with appropriate notice and opportunity for a PBM to be heard and defend against the charges. JUSTIFICATION: PBMs are companies that manage prescription drug benefit programs for health plans. PBMs promote themselves as saving money for health plans and their members, but in reality, their negotiations and the discounts or rebates they get from drug companies are very secretive. PBMs commonly pocket payments from drug manufacturers that ought to be used to lower drug prices, and they accept payments in exchange for giving preference to more expensive drugs. Like a real estate broker or a lawyer, they ought to be required to act in the best interests of the client (i.e., fiduciary relationship). This bill would require that PBMs be licensed by the Health Department and conform to standards established by the Department. PRIOR LEGISLATIVE HISTORY: New bill

FISCAL IMPLICATIONS: None EFFECTIVE DATE: 90 days after it shall become law.